Just when hopes were running high on the fourth Xarelto trial scheduled to begin this October in the US District Court ND Texas, we are informed that it has been postponed until early 2018. The verdicts for the three previous lawsuits went in favor of the defendants Johnson & Johnson's Janssen Pharmaceuticals and Bayer; however, expectations are pinned on this fourth trial as it represents circumstances which are quite different from the previous cases and could bring in a positive verdict for the plaintiff. Thousands of lawsuits have been filed against the defendants due to its severe side-effects including serious internal bleeding. Allegations involve failure to warn the patients and medical community about the associated risks. Xarelto lawsuits are consolidated under MDL 2592 in the US District Court for the Eastern District of Louisiana under Judge Eldon Fallon, and more than 18,000 lawsuits are pending in courts across the country. This delay may bring in settlement news between the defendants and plaintiffs.
